Clinical Research Directory
Browse clinical research sites, groups, and studies.
TRYPTYR as a Treatment for Patients With Dry Eye Disease (DED)
Sponsor: NYU Langone Health
Summary
The purpose of this research study is to determine the effectiveness of TRYPTYR as a treatment for Dry Eye Disease. The primary efficacy variable is change from baseline in the Ocular Surface Disease Index (OSDI) at week 2. The co-primary efficacy variables are change from baseline in the National Eye Institute (NEI) scale of the cornea and NEI scale of the conjunctiva at 1 month (the third visit).
Official title: A Single Center Investigator Initiated Trial Using TRYPTYR as a Treatment for Patients With Dry Eye Disease
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2026-07-06
Completion Date
2027-05-25
Last Updated
2026-07-28
Healthy Volunteers
No
Conditions
Interventions
TRYPTYR (Acoltremon ophthalmic solution 0.003%)
TRYPTYR will be administered one drop in each eye twice daily (once every 12 hours) for 30 days.
Locations (1)
NYU Langone Health
New York, New York, United States